FOCUS ON FOP
Live / Registered — Registered (as of 30 Aug 2022)
What this means for you
Registered since 30 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90393787
- Registration number
- 6834813
- Mark type
- Design + words
- Filed
- 18 Dec 2020
- Published for opposition
- 09 Nov 2021
- Registered
- 30 Aug 2022
- Attorney of record
- Makiko Coffland
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable electronic publications in the nature of brochures, newsletters and pamphlets in the field of disease conditions and treatment
- Class 016 — Paper goods and printed matter: Printed brochures, newsletters, and pamphlets in the field of disease conditions and treatment
- Class 044 — Medical, beauty and agricultural services: Providing a website to patients and healthcare professionals containing healthcare information regarding diseases and treatment of diseases; Educational services in the nature of providing healthcare information regarding diseases and treatment of diseases to patients and healthcare professionals
Owner
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
Prosecution history
- 19 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2022 — NON-FINAL ACTION E-MAILED
- 18 Mar 2022 — SU - NON-FINAL ACTION - WRITTEN